Browsing: NSCLC

Top Line: Should NSCLC patients who aren’t candidates for concurrent chemoradiation receive immunotherapy and radiation?The Study: The standard treatment for…

Top Line: It’s great to see a lung tumor shrink during treatment, but what does that mean for treatment outcomes?The…

Top Line: ! Does treatment of the primary site improve outcomes for patients with brain-only NSCLC metastases?The Study: Over the…

Top Line: Checkmate 816 changed the landscape of definitive surgery for non-small cell lung cancer (NSCLC) with neoadjuvant chemoimmunotherapy.The Study:…

Does accelerated treatment (60 Gy in 25 fractions) improve outcomes for stage III non-small cell lung cancer (NSCLC)? KROG 0903…

Headline: We now have phase 3 data comparing stereotactic body radiation (SBRT) to hypofractionated radiation (HFRT) for stage I non-small…

Headline: Consolidative ablative radiation for oligoprogressive non-small cell lung cancer (NSCLC) corresponds to a 4-fold benefit in progression-free survival with…

We’ve seen several studies identifying several substructures in the heart that are associated with worse survival or more cardiac events…

The LungART trial showed that adjuvant radiation does not improve disease-free survival in patients with resected, N2 NSCLC. More recently,…

Top Line: CheckMate 816 established the benefit of adding nivolumab to neoadjuvant chemo for resectable non-small cell lung cancer (NSCLC).…